Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Glimepiride I.P. 1mg + Voglibose I.P. 0.2mg + Metformin HCL I.P. 500mg Bi-Layered Tablets
Therapeutic Category
Antidiabetic, Diabetic, Endocrinology
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*15
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Vogliviga GM1/0.2 Tablet combines Glimepiride 1mg, Voglibose 0.2mg, and Metformin 500mg in a bi-layered tablet designed to manage type 2 diabetes effectively. Glimepiride helps increase insulin release from the pancreas, Voglibose reduces post-meal blood sugar spikes by delaying carbohydrate absorption, and Metformin improves insulin sensitivity and reduces glucose production in the liver. This combination works on multiple fronts to control blood sugar levels efficiently throughout the day.
Common side effects may include gastrointestinal discomfort such as nausea, abdominal bloating, flatulence, and diarrhea. There is a risk of hypoglycemia, particularly if meals are skipped or dosage is not followed correctly. Long-term use of Metformin may cause vitamin B12 deficiency in some patients.
This medication is indicated for the treatment of type 2 diabetes mellitus, especially for patients who need better control of both fasting and postprandial blood glucose levels.
Not suitable for patients with type 1 diabetes, severe liver or kidney disease, or diabetic ketoacidosis. Regular monitoring of blood sugar levels is necessary during treatment. Alcohol consumption should be avoided. Follow your doctor’s advice strictly.
Store in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.
Composition : Metformin (500mg) SR + Voglibose (0.3mg) Tablet
Composition : Metformin (500mg) SR + Voglibose (0.2mg) Bilayered Smart Tablet
Composition : Glimepiride (2mg) + Metformin (500mg) SR + Voglibose (0.2mg) Bilayered Smart Tablet
Composition : Rosuvastatin 10 mg tablet
Composition : Rosuvastatin (20mg) tablet
Composition : Rosuvastatin 40 mg tablet
Composition : Rosuvastatin 5mg + fenofibrate 160 mg tablet
Composition : Rosuvastatin 20 mg + aspirin 75 mg tablet
Composition : Atorvastatin Calcium I.P. 10mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.